Affordable Access

Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate.

Authors
Type
Published Article
Journal
Bone Marrow Transplantation
0268-3369
Publisher
Nature Publishing Group
Publication Date
Volume
34
Issue
12
Pages
1025–1031
Identifiers
PMID: 15516945
Source
Medline

Abstract

Statistics

Seen <100 times